Is a complete ASBP research report available?

No complete published report is available for Aspire Biopharma Holdings, Inc. (ASBP) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Aspire Biopharma Holdings, Inc. (ASBP)

NASDAQ: ASBP · USD

$6.72

+1.11 (+19.8%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ASBP analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	8.7M
Revenue (ttm)	34.6K
Net income (ttm)	-11.8M
EPS (ttm)	-$145
Shares out	1.3M
Volume	14,179
Beta	0.15

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 34.6K
Net income (ttm): -11.8M
EPS (ttm): -$145
Market cap: 8.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All ASBP indicators

Market & fundamental data

Available fields

170

Groups with data

Currency

USD

Showing 170 of 170 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001847345
Company name	Aspire Biopharma Holdings, Inc.
Country	United States
Country code	US
Cusip	738920305
Enterprise value	$3.6M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US7389203057
Last refreshed	2026-07-31
Market cap	$8.7M
Market cap category	Nano-Cap
Price	$6.72
Price currency	USD
Sector	Healthcare
Sector PE	45.64
Sector PE Fwd	24.21
Sic	2834
Symbol	ASBP
Website	https://aspirebiolabs.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-147.37%
EV/Sales	104.86x
P/B ratio	0.24x
P/S ratio	230.98x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	16.3%
Gross Profit	$5,634
Net Income	$-11.8M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-34,039.68%
ROA	-74.7
ROCE	-69.89
ROIC	-131

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-98.83%
Cagr3y	-91.89%
EPS Growth Quarters	2
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.01
Assets	$7.1M
Cash	$5.9M
Current Assets	$7.1M
Current Liabilities	$3.2M
Debt	$1.5M
Debt Equity	$0.39
Equity	$3.9M
Interest Coverage	-0.28
Liabilities	$3.2M
Long Term Assets	$0
Long Term Liabilities	$96,252
Net Cash	$4.4M
Net Cash By Market Cap	$54.6
Net Debt Equity	$-1.13
Tangible Book Value	$3.9M
Tangible Book Value Per Share	$23.1
WACC	86.25

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.26
Net Working Capital	$-393,095
Quick ratio	1.86
Working Capital	$4M
Working Capital Turnover	$-0.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-222.62%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-98.82%
200-day SMA	83.38
3Y total return	-99.95%
50-day SMA	6.09
50-day SMA vs 200-day SMA	50under200
All Time High	18,960
All Time High Change	-99.96%
All Time High Date	2025-02-12
All Time Low	3.31
All Time Low Change	103.08%
All Time Low Date	2026-05-08
ATR	0.87
Beta	0.15
Beta1y	0.13
Beta2y	1.65
Ch YTD	-95.75
High	6.72
High52	1,050.4
High52 Date	2025-08-18
High52ch	-99.36%
Low	5.94
Low52	3.31
Low52 Date	2026-05-08
Low52ch	103.08%
Ma50ch	10.31%
Premarket Change Percent	8.38
Premarket Price	$6.08
Premarket Volume	194
Price vs 200-day SMA	-91.94%
RSI	51.16
RSI Monthly	18.34
RSI Weekly	23.12
Sharpe ratio	-1.06x
Sortino ratio	-1.6
Total Return	-222.62%
Tr YTD	-95.75
Tr1m	9.45%
Tr1w	-6.8%
Tr3m	-8.2%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-5.4M
Operating margin	-15,707.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,218,044%
Float Percent	94.04%
Net Borrowing	2,677,344
Shares Insiders	5.77%
Shares Institutions	0.99%
Shares Out	1,295,234
Shares Qo Q	83.94%
Shares Yo Y	222.62%
Short Float	9.71%
Short Ratio	0.93
Short Shares	9.13

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted OCF	-6,223,888
Average Volume	55,629.15x
Bv Per Share	23.1
Ch1m	9.45
Ch1w	-6.8
Ch1y	-98.82
Ch3m	-8.2
Ch3y	-99.95
Ch6m	-84.66
Change	19.79%
Change From Open	13.13
Close	5.61
Days Gap	5.88
Dollar Volume	95,282.9
Earnings Date	2026-08-14
Earnings Time	amc
EBIT	$-2.8M
EBITDA	$-2.8M
EPS	$-145
F Score	2
Financing CF	10,720,963
Fiscal Year End	December
Founded	2,021
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-15
Last Report Date	2026-03-31
Last Split Date	2026-05-11
Last Split Type	Reverse
Last10k Filing Date	2026-03-30
Ma150	32.22
Ma150ch	-79.14%
Ma20	6.45
Ma20ch	4.17%
Net CF	4,510,481
Next Earnings Date	2026-08-12
Open	5.94
Optionable	No
Position In Range	100
Post Close	6.72
Postmarket Change Percent	1.04
Postmarket Price	$6.79
Pre Close	5.61
Price Date	2026-07-30
Ptbv Ratio	2.06
Relative Volume	0.25x
Revenue	34,555x
SBC By Revenue	38.8x
Share Based Comp	13,406
Tr6m	-84.66%
Us State	Florida
Volume	14,179
Z Score	-5.11

Aspire Biopharma Holdings, Inc. (ASBP)

Coverage state: Market snapshot only — no published research

Generate the first ASBP analysis

Price

Financial snapshot

Fair-value bridge

Latest news · ASBP

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASBP indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ASBP

Frequently asked questions